Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel
Abstract
Tyrosine kinase inhibitors (TKIs) have dramatically changed the survival of chronic myeloid leukemia (CML) patients, and treatment-free remission (TFR) has recently emerged as a new goal of CML treatment. The aim of this work was to develop recommendations for TKI discontinuation in Latin America (LA), outside of clinical trials. A working group of CML experts from LA discussed 22 questions regarding TFR and reached a consensus for TFR...
Paper Details
Title
Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel
Published Date
Nov 24, 2021
Journal
Volume
5
Issue
23
Pages
4855 - 4863
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History